BBIO | Bridgebio Pharma Inc
Category: Consumer goods
Quick infos Headquarters: Palo Alto, California, United States Trade prices Volume: Market Cap: 7.89B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: August 5, 2021
Earnings History Date EPS / Forecast Revenue / Forecast November 11, 2021 August 5, 2021 -0.66 / -0.971654.02M / 28.49MBeat! May 19, 2021 - / -0.8444- / 18.16MMay 6, 2021 -1.18 / -0.75462K / 27.51MBeat! March 8, 2021 - / -0.8742- / 13.37Mview more
Historical Data Date Price Open High Low Vol Change ER Sep 14, 2021 48.59 50.94 51.20
48.31
752.70K -4.56% Sep 13, 2021 50.91 50.75 51.21
49.93
904.51K 1.11% Sep 10, 2021 50.35 51.44 51.61
49.83
505.37K -1.02% Sep 9, 2021 50.87 49.82 51.96
49.56
784.84K 1.72% Sep 8, 2021 50.01 52.38 52.38
49.68
628.84K -3.23% Sep 7, 2021 51.68 51.14 51.77
50.59
631.02K 0.12% Sep 3, 2021 51.62 51.11 52.06
51.10
779.22K 0.86% Sep 2, 2021 51.18 51.02 51.31
49.84
536.05K 1.07% Sep 1, 2021 50.64 50.04 51.38
49.86
399.45K 1.06% Aug 31, 2021 50.11 48.59 50.32
48.59
861.27K 3.13% view more
News
BridgeBio Pharma and Affiliate Origin Biosciences Announces FDA Acceptance of its New Drug Application for Fosdenopterin for the Treatment of MoCD Type A finance.yahoo.com Oct 5, 2020 7:30 am BridgeBio to buy Eidos Therapeutics in a cash and stock deal valuing Eidos at $2.8 billion marketwatch.com Oct 5, 2020 7:21 am
Analysts Are Betting On BridgeBio Pharma, Inc. (NASDAQ:BBIO) With A Big Upgrade This Week finance.yahoo.com Oct 5, 2020 6:03 am
2 Under-the-Radar Biotech Stocks You'll Wish You Didn't Ignore fool.com Oct 3, 2020 6:07 am
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Sep 3, 2020 5:30 pm
BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures finance.yahoo.com Aug 12, 2020 5:30 pm Adaptive Biotech and BridgeBio shares rocket higher on their first day of trade marketwatch.com Aug 12, 2020 11:25 am BridgeBio prices IPO at $17 a share, above its $14 to $16 price range marketwatch.com Aug 12, 2020 9:24 am
BridgeBio Pharma, Inc. Enters Into Collaboration Agreement With Johns Hopkins University to Accelerate Development of New Medicines in Genetically Driven Diseases finance.yahoo.com Aug 12, 2020 7:30 am
BridgeBio Pharma, Inc. Announces Proposed Offering of $350 Million Convertible Senior Notes finance.yahoo.com Aug 12, 2020 7:00 am BridgeBio Pharma inks licensing pact for its oncology candidates with LianBio in China seekingalpha.com Aug 11, 2020 10:26 pm BridgeBio Pharma EPS misses by $0.23 seekingalpha.com Aug 11, 2020 7:47 pm BioMarin files EU marketing application for vosoritide for type of dwarfism seekingalpha.com Jul 24, 2020 5:07 am
BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update finance.yahoo.com Aug 11, 2020 7:40 am
Ivy Brain Tumor Center and BridgeBio Pharmas QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent Glioblastoma finance.yahoo.com Jul 28, 2020 7:30 am Mid-stage study underway on BridgeBio's infigratinib for bone growth disorder seekingalpha.com Jul 15, 2020 8:10 pm
BridgeBio Pharmas Phoenix Tissue Repair to Highlight Interim Phase 1/2 Study Data in a Presentation at the Society for Pediatric Dermatologys 45th Annual Meeting finance.yahoo.com Jul 10, 2020 7:30 am Mixed shelf roundup - healthcare seekingalpha.com Jul 10, 2020 12:34 am
Hedge Funds Are Nibbling On BridgeBio Pharma, Inc. (BBIO) finance.yahoo.com Jul 5, 2020 3:43 pm
BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update finance.yahoo.com Jul 2, 2020 4:01 pm Talk about Bridgebio Pharma Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
